论文信息 - A retrospective study: Application site pain with the use of crisaborole, a topical phosphodiesterase 4 inhibitor - 字舞流文

A retrospective study: Application site pain with the use of crisaborole, a topical phosphodiesterase 4 inhibitor

D. Rosmarin | S. Gordon | M. J. Her | Christine Pao‐Ling Lin | Samantha C Gordon

[1] M. Lebwohl,et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. , 2016, Journal of the American Academy of Dermatology.

[2] H. Williams,et al. Scoping systematic review of treatments for eczema , 2016 .

[3] Ami A. Shah,et al. Cancer and scleroderma: a paraneoplastic disease with implications for malignancy screening , 2015, Current opinion in rheumatology.

[4] Yuchen Jiao,et al. Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer , 2014, Science.

[5] S. Nakata,et al. Epithelial–mesenchymal transition of the eccrine glands is involved in skin fibrosis in morphea , 2013, The Journal of dermatology.

[6] D. Sugiyama,et al. Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. , 2013, Arthritis and rheumatism.

[7] Ami A. Shah,et al. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies. , 2010, Arthritis and rheumatism.